3 ms·
Biotech firm files bankruptcy w $115M debt; Eli Lilly, Astellas bet on it anyway
- randycupertino 4mo agoLilly is paying $50 million as a "stalking horse" for Sangamo Therapeutics capsid delivery program, "zinc finger" gene-editing and modular integrase platforms and brain disease treatment. Astellas is paying $50 million for the Fabry disease late-stage gene therapy program.